FAIR PRODUCTS, INC. – Trademark Portfolio

Entity Type: 03

FAIR PRODUCTS, INC. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 13 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include F, FST-7, N-TAC, O-TAC, and EXCEED. The owner is based in Cary, NC.

806 Reedy Creek Road

Cary, NC 27513

17 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

FAIR PRODUCTS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (13 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does FAIR PRODUCTS, INC. have?

FAIR PRODUCTS, INC. has 17 U.S. trademarks filed with the USPTO. Of these, 11 registered, 2 abandoned, 4 cancelled.

What trademark classes does FAIR PRODUCTS, INC. file in?

FAIR PRODUCTS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are FAIR PRODUCTS, INC.'s most well-known trademarks?

FAIR PRODUCTS, INC.'s registered trademark portfolio includes well-known marks such as F, FST-7, N-TAC, O-TAC, and EXCEED. These are among 11 currently registered trademarks in the portfolio.

What is FAIR PRODUCTS, INC.'s trademark registration success rate?

FAIR PRODUCTS, INC. has a 65% trademark registration rate, with 11 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.